Abstract
In this Introduction to the series of papers that follow about purinergic receptors, there is a brief history of the discovery of purinergic signalling, the identity of purinoceptors and the current recognition of P1, P2X and P2Y subtypes. An account of key functions mediated by purinoceptors follows, including examples of both short-term and long-term (trophic) signalling and a table showing the selective agonists and antagonists for the purinoceptor subtypes. References to evolution and roles of purinoceptors in pathological conditions are also presented.
References
Abbracchio MP, Burnstock G (1994) Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64(3):445–475
Abbracchio MP, Burnstock G, Boeynaems J-M, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA (2006) International Union of Pharmacology. Update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58(3):281–341
Brake AJ, Wagenbach MJ, Julius D (1994) New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 371(4697):519–523
Burnstock G (1972) Purinergic nerves. Pharmacol Rev 24(3):509–581
Burnstock G (1976) Do some nerve cells release more than one transmitter? Neuroscience 1:239–248
Burnstock G (1978) A basis for distinguishing two types of purinergic receptor. In: Straub RW, Bolis L (eds) Cell membrane receptors for drugs and hormones: a multidisciplinary approach. Raven Press, New York, pp 107–118
Burnstock G (1981) Purinergic receptors. Receptors and recognition, series B, vol 12. Chapman & Hall, London
Burnstock G (1996) Purinoceptors: ontogeny and phylogeny. Drug Dev Res 39(3–4):204–242
Burnstock G (2003) Introduction: ATP and its metabolites as potent extracellular agonists. In: Schwiebert EW (ed) Current topics in membranes, vol 54. Purinergic receptors and signalling. Academic, San Diego, pp 1–27
Burnstock G (2006) Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58(1):58–86
Burnstock G (2007a) Purine and pyrimidine receptors. Cell Mol Life Sci 64(12):1471–1483
Burnstock G (2007b) Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87(2):659–797
Burnstock G (2013) Purinergic signalling: pathophysiology and therapeutic potential. Keio J Med 62(3):63–73
Burnstock G (2015) Intracellular expression of purinoceptors. Purinergic Signal 11(3):275–276
Burnstock G (2016) Short- and long-term (trophic) purinergic signalling. Philos Trans R Soc B: Biol Sci 371(1700):20150422
Burnstock G, Dale N (2015) Purinergic signalling in development and ageing. Purinergic Signal 11(3):277–305
Burnstock G, Kennedy C (1985) Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol 16(5):433–440
Burnstock G, Knight GE (2004) Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 240:31–304
Burnstock G, Verkhratsky A (2012) Evolution of P2X receptors. WIREs Membr Transp Signal 1(2):188–200
Chen JF, Lee CF, Chern Y (2014) Adenosine receptor neurobiology: overview. Int Rev Neurobiol 119:1–49
Dubyak GR, El Moatassim C (1993) Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 265(3 Pt 1):C577–C606
Erlinge D (2011) P2Y receptors in health and disease. Adv Pharmacol 61:417–439
Fountain SJ, Burnstock G (2009) An evolutionary history of P2X receptors. Purinergic Signal 5(3):269–272
Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev 46(2):143–156
Fredholm BB, IJzerman AP, Jacobson KA, Linden J, Müller CE (2011) International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors – an update. Pharmacol Rev 63(1):1–34
Gordon JL (1986) Extracellular ATP: effects, sources and fate. Biochem J 233(2):309–319
Habermacher C, Dunning K, Chataigneau T, Grutter T (2016) Molecular structure and function of P2X receptors. Neuropharmacology 104:18–30
Hattori M, Gouaux E (2012) Molecular mechanism of ATP binding and ion channel activation in P2X receptors. Nature 485(7397):207–212
Jacobson KA, Linden J (2011) Pharmacology of purine and pyrimidine receptors. Adv Pharmacol 61:1–558
Jacobson KA, Gao ZG, Paoletta S, Kiselev E, Chakraborty S, Jayasekara PS, Balasubramanian R, Tosh DK (2015) John Daly lecture: structure-guided drug design for adenosine and P2Y receptors. Comput Struct Biotechnol J 13:286–298
Kawate T, Michel JC, Birdsong WT, Gouaux E (2009) Crystal structure of the ATP-gated P2X4 ion channel in the closed state. Nature 460(7255):592–598
Lustig KD, Shiau AK, Brake AJ, Julius D (1993) Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc Natl Acad Sci U S A 90(11):5113–5117
Maenhaut C, Van Sande J, Libert F, Abramowitz M, Parmentier M, Vanderhaegen JJ, Dumont JE, Vassart G, Schiffmann S (1990) RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. Biochem Biophys Res Commun 173(3):1169–1178
Müller CE (2015) Medicinal chemistry of P2X receptors: allosteric modulators. Curr Med Chem 22(7):929–941
Nicke A, Baumert HG, Rettinger J, Eichele A, Lambrecht G, Mutschler E, Schmalzing G (1998) P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO J 17(11):3016–3028
North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82(4):1013–1067
O’Connor SE, Dainty IA, Leff P (1991) Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol Sci 12(4):137–141
Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50(3):413–492
Valera S, Hussy N, Evans RJ, Adani N, North RA, Surprenant A, Buell G (1994) A new class of ligand-gated ion channel defined by P2X receptor for extra-cellular ATP. Nature 371(6497):516–519
Webb TE, Simon J, Krishek BJ, Bateson AN, Smart TG, King BF, Burnstock G, Barnard EA (1993) Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett 324(2):219–225
Compliance with Ethical Standards
Conflicts of Interest
The author declares that he has no conflicts of interest.
Ethical Approval
This article does not contain any studies with human participants or animals performed by the author.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Burnstock, G. (2017). Introduction to the Special Issue on Purinergic Receptors. In: Atassi, M. (eds) Protein Reviews. Advances in Experimental Medicine and Biology(), vol 1051. Springer, Singapore. https://doi.org/10.1007/5584_2017_12
Download citation
DOI: https://doi.org/10.1007/5584_2017_12
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-7610-7
Online ISBN: 978-981-10-7611-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)